نتایج جستجو برای: myeloperoxidase mpo

تعداد نتایج: 7529  

Journal: :Blood 2013
Dragana Odobasic A Richard Kitching Yuan Yang Kim M O'Sullivan Ruth C M Muljadi Kristy L Edgtton Diana S Y Tan Shaun A Summers Eric F Morand Stephen R Holdsworth

Myeloperoxidase (MPO) is important in intracellular microbial killing by neutrophils but extracellularly causes tissue damage. Its role in adaptive immunity and T-cell-mediated diseases is poorly understood. Here, T-cell responses in lymph nodes (LNs) were enhanced by MPO deletion or in vivo inhibition, causing enhanced skin delayed-type hypersensitivity and antigen (Ag)-induced arthritis. Resp...

2013
Irina V. Gorudko Alexey V. Sokolov Ekaterina V. Shamova Natalia A. Grudinina Elizaveta S. Drozd Ludmila M. Shishlo Daria V. Grigorieva Sergey B. Bushuk Boris A. Bushuk Sergey A. Chizhik Sergey N. Cherenkevich Vadim B. Vasilyev Oleg M. Panasenko

Myeloperoxidase (MPO) is a heme-containing enzyme released from activated leukocytes into the extracellular space during inflammation. Its main function is the production of hypohalous acids that are potent oxidants. MPO can also modulate cell signaling and inflammatory responses independently of its enzymatic activity. Because MPO is regarded as an important risk factor for cardiovascular dise...

Journal: :JAMA 2001
R Zhang M L Brennan X Fu R J Aviles G L Pearce M S Penn E J Topol D L Sprecher S L Hazen

CONTEXT Myeloperoxidase (MPO), a leukocyte enzyme that promotes oxidation of lipoproteins in atheroma, has been proposed as a possible mediator of atherosclerosis. OBJECTIVE To determine the association between MPO levels and prevalence of coronary artery disease (CAD). DESIGN, SETTING, AND PATIENTS Case-control study conducted from July to September 2000 in a US tertiary care referral cent...

Journal: :Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006
Jacek Borawski Beata Naumnik Alicja Rydzewska-Rosołowska Michał Myśliwiec

Myeloperoxidase up-regulation during haemodialysis: is heparin the missing link? Sir, We read with interest the recent series of articles showing a striking increase in blood myeloperoxidase (MPO) levels during haemodialysis (HD) sessions [1–3]. In this setting, the enzyme is traditionally regarded as a marker of neutrophil degranulation and thus, of dialyser membrane biocompat-ibility, as well...

Journal: :Chemistry 2023

Hypochlorous acid (HClO) is a common reactive oxygen species (ROS), with high chemical reactivity. Myeloperoxidase (MPO) an enzyme that catalyzes in vivo redox reactions between H2O2 and Cl− to produce HClO. Abnormal levels of HClO MPO may lead oxidative stress, irreversible tissue damage and, thus, serious diseases; they are thus becoming important biomarkers therapeutic targets. In this work,...

Objective(s): Sepsis can result in severe organ injury by provoking inflammatory cascades and oxidative stress. Several studies are currently underway to find a drug with anti-inflammatory effects to prevent mortality and morbidity during sepsis. The present study was undertaken to assess the effects of metformin on oxidative stress and antioxidant status in sepsis induced by the Cecal Ligation...

2016
Aysegul Dogan Demir Nilufer Goknar Faruk Oktem Hayriye Arzu Ergen Akif Nuri Dogan Selcuk Uzuner Aysel Vehapoglu Mebrure Yazıcı

Background: Familial Mediterranean Fever (FMF) is the most common autoinflammatory disease. Autoinflammatory disorders are characterized by exaggerated immune system responses. Neutrophils and their byproduct, myeloperoxidase, are important components of the innate immune system. In the present study, we searched for myeloperoxidase gene polymorphisms in FMF patients. Methodology/Principal Find...

2017
Wenzhen Ji Yu Zhang

Aim The objective of this study was to explore the genetic association of myeloperoxidase (MPO) gene polymorphisms with risk of Alzheimer's disease (AD). Methods Blood samples were collected from 116 AD patients and 134 age and gender matched healthy individuals. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was utilized to confirm MPO polymorphisms in promoter...

Journal: :Clinical chemistry 2007
Lysann Mauch Andreas Lun Maurice R G O'Gorman John S Harris Ilka Schulze Arturo Zychlinsky Tobias Fuchs Uta Oelschlägel Sebastian Brenner Dolphe Kutter Angela Rösen-Wolff Joachim Roesler

BACKGROUND The flow cytometric dihydrorhodamine 123 (DHR) assay is used as a screening test for chronic granulomatous disease (CGD), but complete myeloperoxidase (MPO) deficiency can also lead to a strongly decreased DHR signal. Our aim was to devise simple laboratory methods to differentiate MPO deficiency (false positive for CGD) and NADPH oxidase abnormalities (true CGD). METHODS We measur...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید